Passive transfer studies with type II collagen antibody in B10.D2/old and new line and C57Bl/6 normal and beige (Chediak-Higashi) strains: evidence of important roles for C5 and multiple inflammatory cell types in the development of erosive arthritis.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 3580014)

Published in Arthritis Rheum on April 01, 1987

Authors

W C Watson, P S Brown, J A Pitcock, A S Townes

Articles citing this

Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis. J Clin Invest (2002) 2.56

Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol (2003) 1.81

Agalactosyl glycoforms of IgG autoantibodies are pathogenic. Proc Natl Acad Sci U S A (1994) 1.65

Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther (2006) 1.32

Neutrophils in a mouse model of autoantibody-mediated arthritis: critical producers of Fc receptor gamma, the receptor for C5a, and lymphocyte function-associated antigen 1. Arthritis Rheum (2010) 1.31

Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis. Immunology (2006) 1.21

The plasminogen activator/plasmin system is essential for development of the joint inflammatory phase of collagen type II-induced arthritis. Am J Pathol (2005) 1.13

Role of C3a receptors, C5a receptors, and complement protein C6 deficiency in collagen antibody-induced arthritis in mice. J Immunol (2011) 1.10

Flk-1+ mesenchymal stem cells aggravate collagen-induced arthritis by up-regulating interleukin-6. Clin Exp Immunol (2009) 1.09

Chronic development of collagen-induced arthritis is associated with arthritogenic antibodies against specific epitopes on type II collagen. Arthritis Res Ther (2005) 0.96

Experimental arthritis in C57black/6 normal and beige (Chediak-Higashi) mice: in vivo and in vitro observations on cartilage degradation. Ann Rheum Dis (1988) 0.93

Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis. Arthritis Res Ther (2004) 0.92

The role and clinical implications of G6PI in experimental models of rheumatoid arthritis. Arthritis Res Ther (2004) 0.90

The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody. Arthritis Rheum (2010) 0.89

Human HLA-DR beta gene hypervariable region homology in the biobreeding BB rat: selection of the diabetic-resistant subline as a rheumatoid arthritis research tool to characterize the immunopathologic response to human type II collagen. J Exp Med (1990) 0.81

Destructive effects of murine arthritogenic antibodies to type II collagen on cartilage explants in vitro. Arthritis Res Ther (2005) 0.80

Rheumatoid arthritis viewed using a headache paradigm. Arthritis Res (2000) 0.77

Articles by these authors

Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med (1977) 10.09

Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med (1982) 3.06

The venders of medicines advertised in eighteenth-century Bath newspapers. Med Hist (1975) 2.90

Humoral and cellular sensitivity to collagen in type II collagen-induced arthritis in rats. J Clin Invest (1978) 2.84

Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med (1972) 2.79

Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest (1982) 2.29

Health care abuse. CMAJ (1994) 2.22

Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum (1979) 2.16

Collagen autoimmune arthritis. Annu Rev Immunol (1984) 2.10

Lymphocytes in Whipple's disease. Lancet (1968) 2.06

Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med (1985) 2.01

Aortoenteric fistula. Incidence, presentation recognition, and management. Ann Surg (1982) 1.97

Herbalists and medical botanists in mid-nineteenth-century Britain with special reference to Bristol. Med Hist (1982) 1.73

Collagen-induced arthritis in rats. Comparison of vitreous and cartilage-derived collagens. Arthritis Rheum (1979) 1.71

Medicines advertised in eighteenth-century Bath newspapers. Med Hist (1976) 1.65

Technique of controlled reperfusion of the transplanted lung in humans. Ann Thorac Surg (2000) 1.62

Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia. J Exp Med (1991) 1.55

Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med (1985) 1.52

The occurrence of cryoproteins in synovial fluid; the association of a complement-fixing activity in rheumatoid synovial fluid with cold-precipitable protein. J Clin Invest (1971) 1.51

Incidence and specificity of antibodies to types I, II, III, IV, and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by 125I-radioimmunoassay. Arthritis Rheum (1983) 1.51

Collagen-induced arthritis in rats: antigen-specific suppression of arthritis and immunity by intravenously injected native type II collagen. J Immunol (1983) 1.49

Apical and basolateral endocytic pathways of MDCK cells meet in acidic common endosomes distinct from a nearly-neutral apical recycling endosome. Traffic (2000) 1.49

Serum transfer of collagen-induced arthritis. II. Identification and localization of autoantibody to type II collagen in donor and recipient rats. Arthritis Rheum (1983) 1.48

Collagen-induced polyarthritis in rats: a study of native type II collagen for adjuvant activity. J Immunol (1980) 1.43

Hypertonicity of the cricopharyngeal sphincter: A cause of globus sensation. Lancet (1974) 1.41

Globus and headache: common symptoms of the irritable bowel syndrome. Can Med Assoc J (1978) 1.35

The providers of medical treatment in mid-nineteenth-century Bristol. Med Hist (1980) 1.33

Topics in clinical medicine. Complement levels in disease. Johns Hopkins Med J (1967) 1.29

Intestinal disaccharidase activity in rosacea. Br Med J (1966) 1.28

Acceleration of onset of collagen-induced arthritis by intra-articular injection of tumour necrosis factor or transforming growth factor-beta. Clin Exp Immunol (1992) 1.22

Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med (1980) 1.21

Preliminary criteria for the classification of systemic lupus erythematosus (SLE). Evaluation in early diagnosed SLE and rheumatoid arthritis. Arthritis Rheum (1974) 1.16

Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science (1982) 1.16

Nineteenth-century American health reformers and the early nature cure movement in Britain. Med Hist (1988) 1.14

Production of renomedullary prostaglandins by renomedullary interstitial cells grown in tissue culture. Circ Res (1972) 1.12

Renal medullary calcifications: a light and electron microscopic study. J Urol (1971) 1.12

Auricular chondritis in rats. An experimental model of relapsing polychondritis induced with type II collagen. J Exp Med (1981) 1.12

Collagen autoimmunity and arthritis. FASEB J (1988) 1.11

Impaired cell-mediated immunity in systemic lupus erythematosus (SLE). A controlled study of 23 untreated patients. Am J Med (1975) 1.09

Studies on intestinal pH by radiotelemetering. Gut (1965) 1.09

Chronic intestinal ischaemia. Br Med J (1967) 1.08

Epigastric bruits in patients with and without celiac axis compression. A phonoarteriographic study. Ann Intern Med (1973) 1.08

Medically qualified naturopaths and the General Medical Council. Med Hist (1991) 1.07

The vicissitudes of herbalism in late nineteenth- and early twentieth-century Britain. Med Hist (1985) 1.06

Female pills and the reputation of iron as an abortifacient. Med Hist (1977) 1.06

Celiac axis compression: experience with 20 patients and a critical appraisal of the syndrome. Ann Intern Med (1977) 1.05

Renomedullary interstitial cell tumor (formerly fibroma of renal medulla). Hum Pathol (1972) 1.05

Type II collagen-induced autoimmune sensorineural hearing loss and vestibular dysfunction in rats. Ann Otol Rhinol Laryngol (1983) 1.04

Controlled trial of cyclophosphamide in rheumatoid arthritis. Arthritis Rheum (1976) 1.04

Gonadal function, testicular histology, and meiosis following cyclophosphamide therapy in patients with nephrotic syndrome. J Pediatr (1976) 1.04

Composition of the helical internal components of influenza virus as revealed by immunogold labeling/electron microscopy. Virology (1992) 1.01

Early renal changes in sickle cell anemia. Arch Pathol (1970) 1.01

Abdominal pain in a mixed adult African population: diagnosis on first presentation. J Trop Med Hyg (1968) 1.01

Renomedullary antihypertensive function in accelerated (malignant) hypertension. Observations on renomedullary interstitial cells. J Clin Invest (1972) 1.00

Bacterial L-form isolation from inflammatory bowel disease patients. Gastroenterology (1983) 0.99

Alkaline phosphatase levels in normal and diseased small bowel. Gut (1968) 0.98

Performance of a rosette assay between lymphocytes and sheep erythrocytes at elevated temperatures to study patients with cancer and other diseases. Clin Immunol Immunopathol (1976) 0.98

Radiologic recommendations in cases of gastric ulcer. CMAJ (1993) 0.98

Glycosaminoglycans of the rat renomedullary interstitium: ultrastructural and biochemical observations. Exp Mol Pathol (1988) 0.97

Type II collagen-induced autoimmune otospongiosis. A preliminary report. Ann Otol Rhinol Laryngol (1983) 0.97

Effect of cyclophosphamide, hydrocortisone and levamisole on collagen-induced arthritis in rats. Arthritis Rheum (1981) 0.97

Management of adenocarcinoma in a columnar-lined esophagus. Ann Thorac Surg (1985) 0.97

Effect of calcitonin and vitamin D in osteoporosis. Calcif Tissue Int (1989) 0.96

Direct vision of the ampulla of Vater through the gastroduodenal fiberscope. Lancet (1966) 0.95

The role of collagen autoimmunity in animal models and human diseases. J Invest Dermatol (1982) 0.95

Juxtaglomerular cells grown as monolayer cell culture contain renin, angiotensin I-converting enzyme, and angiotensin I and II/III. Circ Res (1982) 0.95

Detection and quantitation of tetanus antitoxin in blood donations. J Clin Pathol (1975) 0.95

Focal myositis in the hand. J Hand Surg Am (1988) 0.93

Sebaceous lesions of the parotid. Report of two cases. Arch Pathol (1966) 0.93

Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum (1986) 0.93

Highly localized tracks of human immunodeficiency virus type 1 Nef in the nucleus of cells of a human CD4+ T-cell line. Proc Natl Acad Sci U S A (1993) 0.93

Arthritis in viral hepatitis. Report of two cases and review of the literature. Johns Hopkins Med J (1973) 0.92

Radiotelemetering studies of jejunal pH before and after vagotomy and gastro-enterostomy. Gut (1966) 0.92

Autoantibodies to murine type II collagen in collagen-induced arthritis: a comparison of susceptible and nonsusceptible strains. J Immunol (1996) 0.92

"Bingo brain". Can Med Assoc J (1982) 0.91

Biliary excretion of aluminum in aluminum osteodystrophy with liver disease. Ann Intern Med (1986) 0.91

Phonoenterography: the recording and analysis of bowel sounds. Gut (1967) 0.89

Molecular interactions between human B-cell progenitors and the bone marrow microenvironment. Exp Cell Res (1996) 0.89

Duplication of the ileum with heterotopic gastric mucosa pseudomyxoma peritonei and nonrotation of the midgut. Gastroenterology (1974) 0.89

Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis. Clin Exp Immunol (1993) 0.89

The renal antihypertensive endocrine function: its relation to cytochrome P-450. J Hypertens (1989) 0.89

Complement in synovial fluid. Johns Hopkins Med J (1970) 0.89

Cardiopulmonary bypass and thyroid function: a "euthyroid sick syndrome". Ann Thorac Surg (1991) 0.88

Complement-fixing activity of rheumatoid synovial fluid. Ann Rheum Dis (1972) 0.88

Reversal of hypertension by transplants and lipid extracts of cultured renomedullary interstitial cells. Lab Invest (1977) 0.88

Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig. J Immunol (1976) 0.88

Paravertebral synovial osteochondromatosis. A case report. Spine (Phila Pa 1976) (1986) 0.88

SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies. Arthritis Rheum (1991) 0.87

Familial juvenile polyposis of the colon. Cancer (1970) 0.87

Benign mucous gland adenoma of the bronchus. Arch Pathol (1967) 0.87

Black bones following long-term minocycline treatment. Arch Pathol Lab Med (1991) 0.86

Limiting initial resuscitation of uncontrolled hemorrhage reduces internal bleeding and subsequent volume requirements. J Trauma (1995) 0.86

Fat digestion and absorption in the adrenalectomized rat. J Lipid Res (1966) 0.86

Aortoduodenal fistula; endoscopic diagnosis. Dig Dis Sci (1980) 0.86

Collagen-induced arthritis in rats. Examination of the epitope specificities of circulating and cartilage-bound antibodies produced by outbred and inbred rats using cyanogen bromide-derived peptides purified from heterologous and homologous type II collagens. J Immunol (1992) 0.85